Short Jay M PhD's Form 4 filing
BioAtla, Inc. (BCAB) · filed Nov 30, 2021
- Accession no.
- 0001209191-21-067217
- Filed
- Nov 30, 2021
- Trade date
- Nov 22-24, 2021
- Filing delay
- 8 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.46M. It was filed 8 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Short Jay M PhDCIK 0001205375 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2021 | Common Stock | SSaleDisposed | −15,675 | $26.24 | −$411,312 | 1,425,833 | Direct | |
| Nov 23, 2021 | Common Stock | SSaleDisposed | −15,861 | $24.29 | −$385,263.69 | 1,409,972 | Direct | |
| Nov 23, 2021 | Common Stock | SSaleDisposed | −9,082 | $26.04 | −$236,495.28 | 1,400,890 | Direct | |
| Nov 24, 2021 | Common Stock | SSaleDisposed | −6,311 | $24.05 | −$151,779.55 | 1,394,579 | Direct | |
| Nov 24, 2021 | Common Stock | SSaleDisposed | −5,852 | $25.00 | −$146,300 | 1,388,727 | Direct | |
| Nov 24, 2021 | Common Stock | SSaleDisposed | −4,859 | $25.77 | −$125,216.43 | 1,383,868 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.